Diabetes, Obesity and Metabolism


Publication Venue For

  • Dissection of hepatic versus extra-hepatic insulin clearance: Ethnic differences in childhood.  20:2869-2875. 2018
  • Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: Subgroup analysis across the SCALE and phase II randomized trials.  18:430-435. 2016
  • Implications of Look AHEAD for clinical trials and clinical practice.  16:1183-1191. 2014
  • Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.  14:40-46. 2012
  • A link between endoplasmic reticulum stress-induced β-cell apoptosis and the group VIA Ca2+-independent phospholipase A2 (iPLA2β).  12:93-98. 2010
  • PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: Baseline health and healthcare utilization of the US sample.  10:1248-1260. 2008
  • Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): The Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.  8:49-57. 2006
  • Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes.  8:110-115. 2006
  • Treatment of isolated systolic hypertension in diabetes mellitus type 2.  8:381-387. 2006
  • Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes.  6:363-366. 2004
  • The neointimal response ot endovascular injury is increased in obese Zucker rats.  5:415-423. 2003
  • Clinical evidence of thiazolidinedione-induced improvement of pancreatic β-cell function in patients with type 2 diabetes mellitus.  4:56-59. 2002
  • International Standard Serial Number (issn)

  • 1462-8902
  • Electronic International Standard Serial Number (eissn)

  • 1463-1326